Demarquoy J. Effects of micro and nano plastics on renal health. World J Nephrol 2026; 15(1): 115039 [DOI: 10.5527/wjn.v15.i1.115039]
Corresponding Author of This Article
Jean Demarquoy, PhD, Université de Bourgogne Europe, Institut Agro-INRAe, 6 Blvd Gabriel, Dijon 21000, France. jean.demarquoy@u-bourgogne.fr
Research Domain of This Article
Biology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Nephrol. Mar 25, 2026; 15(1): 115039 Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.115039
Effects of micro and nano plastics on renal health
Jean Demarquoy
Jean Demarquoy, Université de Bourgogne Europe, Institut Agro-INRAe, Dijon 21000, France
Author contributions: This paper was conceived, written, and revised solely by Demarquoy J.
Conflict-of-interest statement: The author reports no relevant conflicts of interest for this article.
Corresponding author: Jean Demarquoy, PhD, Université de Bourgogne Europe, Institut Agro-INRAe, 6 Blvd Gabriel, Dijon 21000, France. jean.demarquoy@u-bourgogne.fr
Received: October 9, 2025 Revised: October 27, 2025 Accepted: January 7, 2026 Published online: March 25, 2026 Processing time: 159 Days and 13.7 Hours
Abstract
Research on microplastics (MPs) and kidney health is rapidly expanding, yet major knowledge gaps remain. Human exposure remains poorly characterized, with limited data on MPs levels in drinking water, food, indoor air, urine, blood, and kidney tissues. Most animal models rely on high-dose, short-term exposures, whereas studies employing environmentally realistic doses and long-term designs are required to evaluate links with chronic kidney disease and fibrosis. Mechanistic insights are also incomplete; the roles of ferroptosis, pyroptosis, and complement activation, as well as the influence of particle size, shape, polymer type, and surface charge, warrant further investigation. Co-exposures are another critical issue, as MPs act as vectors for heavy metals, persistent organic pollutants, and plastic additives, while also interacting with the gut microbiota and immune system. Clinical implications are particularly concerning: Dialysis fluids, intravenous solutions, and medical devices may represent unrecognized sources of exposure. Addressing these gaps will require multidisciplinary approaches, harmonized detection methods, and clinical monitoring to assess the burden and health consequences of MPs in vulnerable populations. This review underscores the kidney as a potential target organ for MP accumulation and highlights the urgent need for human biomonitoring.
Core Tip: Microplastics and nanoplastics are emerging environmental contaminants capable of reaching the human kidney through ingestion, inhalation, and medical exposure. Experimental data reveal that microplastics accumulate in renal tissue, inducing oxidative stress, endoplasmic reticulum stress, inflammation, autophagy, and ferroptosis. Co-exposure with metals or plastic additives enhances nephrotoxicity, while early human findings confirm their presence in kidney tissue and dialysis fluids. This review integrates mechanistic, experimental, and clinical evidence, highlighting the kidney as a vulnerable target organ and calling for standardized detection methods, multi-omics approaches, and biomonitoring to assess the health burden of plastic exposure.